Let’s Talk Addiction and Recovery (August 2022)
Overdose Awareness Day & National Recovery Month
By Lisa Stangl
This was originally published for Hazelden Betty Ford Foundation’s monthly Recovery Advocacy Update. If you’d like to receive our advocacy emails, subscribe today.
This month’s featured videos, podcasts, webinars and events highlight International Overdose Awareness Day on August 31, along with preparations for celebrating Recovery Month in September. Check them out, mark your calendars and share with your networks.
MOBILIZE RECOVERY 2022 — SAVE THE DATE
Friends in Minnesota and neighboring Wisconsin, mark your calendar to join us as we celebrate recovery and one of the world’s greatest sports rivalries — the Minnesota Vikings versus the Green Bay Packers.
Sunday, September 11
1 to 3 p.m.
Hazelden Betty Ford Foundation
680 Stewart Avenue
St. Paul, MN 55102
Alongside community partners and special guests, we’ll be hosting a FREE, sober, outdoor tailgate party and welcoming the Mobilize Recovery Across America tour bus as it navigates its way through the U.S. during National Recovery Month. This festive event on pro football’s opening weekend will feature food hot off the grill, zero-proof beverages, resources, music, an outdoor TV to watch pre-game coverage, games and fellowship. You will also have the opportunity to sign the Mobilize Recovery bus just prior to the big game’s 3:25 p.m. kickoff, before the bus departs for its next stop, near Green Bay in Manitowoc, Wisconsin.
Watch for additional details to arrive in your inbox later this month.
NEW PODCASTS
How Do We Contain the Fentanyl Crisis? A Panel of Experts Weighs In
“Let’s Talk Addiction & Recovery” podcast host William C. Moyers speaks with four of his brilliant colleagues about the state of the fentanyl epidemic. Now linked to 70% of overdose deaths, fentanyl is now appearing in non-opioids like benzodiazepines, MDMA and marijuana. How did we get here? How can parents and communities limit the deadliness? And how is the medical community responding? Tune in to learn more from Hazelden Betty Ford Chief Medical Officer Alta DeRoo, MD; medical director and psychiatrist Stephen Delisi, MD; research scientist and clinical psychologist Quyen Ngo, PhD; and pharmacist/trainer Kerry Hettinger, PharmD, RPh.
NEW WEBINARS
Overdose: Who’s Most at Risk and How to Help
Drug overdose deaths continue to rise in the United States, with nearly 500,000 lives lost since 1999 from opioid use alone. The deadly trend has especially dire implications for people of color who have been disproportionately impacted by the opioid epidemic. Join Hazelden Betty Ford clinical leaders Manuel Garcia and Lydia Burr to take a closer look at the symptoms and causes of drug overdose and examine statistics related to the disproportionate impact on people of color. You will gain insight into culturally appropriate, evidence-based approaches for working with underrepresented populations as well as clinical interventions to educate clients about the dangers associated with substances and overdose.
Advanced Approaches to the Opioid Epidemic
The emergence of nitazenes. The co-occurrence of opioid and stimulant use disorders. The proliferation of fentanyl-adulterated counterfeit pills. At every harrowing new turn, the evolving opioid epidemic presents added complexities and urgent clinical challenges. Data show the deadly reach of the epidemic imperils Americans of every demographic and walk of life. Join Hazelden Betty Ford’s chief medical officer, Alta DeRoo, MD, along with research scientist/clinical psychologist, Quyen Ngo, PhD, and pharmacist/trainer, Kerry Hettinger, PharmD, RPh to examine advanced treatment approaches, consider integrated risk reduction strategies and identify the most-effective overdose prevention measures.
Advancing Overdose Awareness and Prevention
International Overdose Awareness Day (IOAD), observed annually on August 31, represents the world’s largest annual campaign to end overdose. Communities around the globe mark the day with events aimed at raising awareness about overdose, reducing the stigma of drug-related death and advancing evidence-based strategies and practices such as the use of naloxone. Join pharmacist, trainer and technical consultant Kerry Hettinger, PharmD, RPh, and psychiatrist Stephen Delisi, MD, to review the history and use of naloxone to reverse the effects of opioid overdose and discuss the vital role all members of the healthcare team can play in increasing awareness and availability of this lifesaving medication.
Lisa Stangl is a director of marketing strategy for the Hazelden Betty Ford Foundation.
